Antimetabolites.
作者信息
Allegra C J, Grem J L, Chu E, Johnston P, Yeh G C, Chabner B A
出版信息
Cancer Chemother Biol Response Modif. 1990;11:1-28.
PMID:2223392
Abstract
摘要
相似文献
1
Antimetabolites.抗代谢物
Cancer Chemother Biol Response Modif. 1990;11:1-28.
2
Antimetabolites.抗代谢物。
Cancer Chemother Biol Response Modif. 1996;16:1-27.
3
Cancer chemotherapy and biological response modifiers annual 16. Introduction.
Cancer Chemother Biol Response Modif. 1996;16:xvii-xviii.
4
Antimetabolites.抗代谢物。
Cancer Chemother Biol Response Modif. 1993;14:1-25.
5
1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.1-（3-C-乙炔基-β-D-核糖-戊呋喃糖基）胞嘧啶（ECyd，TAS-106）1：抗肿瘤作用及作用机制。
Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):609-19. doi: 10.1081/NCN-100002337.
6
Antimetabolites.抗代谢物。
Cancer Chemother Biol Response Modif. 1987;9:1-22.
7
Antimetabolites.
Cancer Chemother Biol Response Modif. 1997;17:1-39.
8
In vitro activity and mechanism of action of a duplex and multidrug of ethynylcytidine and 5-fluorodeoxyuridine.乙炔基胞苷与5-氟脱氧尿苷双链体及多药组合的体外活性与作用机制
Nucleic Acids Symp Ser (Oxf). 2008(52):651. doi: 10.1093/nass/nrn329.
9
Properties of purine and pyrimidine analogs.嘌呤和嘧啶类似物的特性。
Adv Enzyme Regul. 1991;31:433-43. doi: 10.1016/0065-2571(91)90028-k.
10
Antimetabolites.
Cancer Chemother Biol Response Modif. 1988;10:1-22.
引用本文的文献
1
Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.具有相反共轭键极性的甲氨蝶呤/明胶共轭物的表征及甲氨蝶呤的体外释放
Pharm Res. 2000 Oct;17(10):1309-15. doi: 10.1023/a:1026460023503.
Zotero 插件